Lung, Breast and Colorectal Cancer Incidence by Socioeconomic Status in Spain: A Population-Based Multilevel Study.

breast cancer colorectal cancer epidemiology lung cancer population-based study socioeconomic inequalities

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
05 Jun 2021
Historique:
received: 14 04 2021
revised: 27 05 2021
accepted: 31 05 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

Socioeconomic inequalities in cancer incidence are not well documented in southern Europe. We aim to study the association between socioeconomic status (SES) and colorectal, lung, and breast cancer incidence in Spain. We conducted a multilevel study using data from Spanish population-based cancer registries, including incident cases diagnosed for the period 2010-2013 in nine Spanish provinces. We used Poisson mixed-effects models, including the census tract as a random intercept, to derive cancer incidence rate ratios by SES, adjusted for age and calendar year. Male adults with the lowest SES, compared to those with the highest SES, showed weak evidence of being at increased risk of lung cancer (risk ratio (RR): 1.18, 95% CI: 0.94-1.46) but showed moderate evidence of being at reduced risk of colorectal cancer (RR: 0.84, 95% CI: 0.74-0.97). Female adults with the lowest SES, compared to those with the highest SES, showed strong evidence of lower breast cancer incidence with 24% decreased risk (RR: 0.76, 95% CI: 0.68-0.85). Among females, we did not find evidence of an association between SES and lung or colorectal cancer. The associations found between SES and cancer incidence in Spain are consistent with those obtained in other European countries.

Identifiants

pubmed: 34198798
pii: cancers13112820
doi: 10.3390/cancers13112820
pmc: PMC8201149
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Spanish National Health Institute Carlos III Miguel Servet-I Investigator grant/award
ID : CP17/00206-EU-FEDER
Organisme : Instituto de Salud Carlos III (ISCIII)
ID : PI18/01593
Organisme : Asociación Española Contra el Cáncer (AECC)
ID : PROYE20023SÁNC
Organisme : Cancer Epidemiological Surveillance Subprogram (VICA) from the CIBER Epidemiologia y Salud Pública (CIBERESP) from the Instituto de Salud Carlos III
Organisme : La Caixa Foundation

Références

Br J Cancer. 2011 May 24;104(11):1791-6
pubmed: 21559020
J Epidemiol Community Health. 2013 Jan;67(1):6-13
pubmed: 22826293
Radiol Oncol. 2020 Feb 19;54(1):1-13
pubmed: 32074075
BMC Cancer. 2008 Sep 26;8:271
pubmed: 18822122
J Thorac Oncol. 2015 Feb;10(2):256-63
pubmed: 25376515
Biometrics. 1987 Sep;43(3):671-81
pubmed: 3663823
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
Gac Sanit. 2021 Mar-Apr;35(2):113-122
pubmed: 32014314
PLoS One. 2014 Feb 27;9(2):e89513
pubmed: 24586838
Int J Environ Res Public Health. 2019 Jan 22;16(3):
pubmed: 30678244
Public Health. 2018 Jan;154:1-10
pubmed: 29128730
Front Oncol. 2018 Sep 25;8:402
pubmed: 30319967
Eur J Cancer Prev. 2018 Jul;27(4):391-398
pubmed: 27879493
Clin Colon Rectal Surg. 2009 Nov;22(4):191-7
pubmed: 21037809
Lancet Oncol. 2013 Nov;14(12):1165-74
pubmed: 24131614
Int J Public Health. 2012 Oct;57(5):827-35
pubmed: 22314543
Clin Epidemiol. 2020 Jul 21;12:797-806
pubmed: 32801917
BMJ Open. 2020 Nov 26;10(11):e041714
pubmed: 33243814
Ann Oncol. 2010 May;21 Suppl 3:iii43-51
pubmed: 20427360
Post Reprod Health. 2014 Mar 13;20(1):8-10
pubmed: 24879773
Cancer Causes Control. 2010 Jul;21(7):1117-30
pubmed: 20349125
PLoS One. 2014 Oct 20;9(10):e109706
pubmed: 25329578
BMC Cancer. 2014 Feb 13;14:87
pubmed: 24524213
Front Oncol. 2019 Apr 04;9:233
pubmed: 31019897

Auteurs

Daniel Redondo-Sánchez (D)

Non-Communicable Disease and Cancer Epidemiology Group, Instituto de Investigación Biosanitaria de Granada, ibs.GRANADA, Calle Doctor Azpitarte 4, 18012 Granada, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), 28029 Madrid, Spain.
Andalusian School of Public Health, Cuesta del Observatorio 4, 18080 Granada, Spain.

Rafael Marcos-Gragera (R)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), 28029 Madrid, Spain.
Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Av. França, s/n, 17004 Girona, Spain.
Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), 17190 Girona, Spain.

Marià Carulla (M)

Tarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Hospital Universitari Sant Joan de Reus, Av. Josep Laporte, 2, 43204 Reus, Spain.
Pere Virgili Health Research Institute (IISPV), Av. Josep Laporte, 2, 43204 Reus, Spain.

Arantza Lopez de Munain (A)

Basque Country Cancer Registry, Health Department, Basque Government, Calle Donostia, 1, 01010 Vitoria-Gasteiz, Spain.

Consol Sabater Gregori (C)

Castellón Cancer Registry, Comunitat Valenciana Cancer Information System, Department of Health, Autonomous Government of Comunitat Valenciana, Av. De Cataluña, 21, 46020 València, Spain.

Rosario Jimenez Chillarón (R)

Cuenca Cancer Registry, Department of Public Health, Autonomous Government of Castilla la Mancha, Calle de las Torres, 43, 16071 Cuenca, Spain.

Marcela Guevara (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), 28029 Madrid, Spain.
Navarra Public Health Institute, Calle Leyre, 15, 31003 Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, Calle Irunlarrea, 3, 31008 Pamplona, Spain.

Olivier Nuñez (O)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), 28029 Madrid, Spain.
Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, National Institute of Health Carlos III, Av. Monforte de Lemos, 5, 28029 Madrid, Spain.

Pablo Fernández-Navarro (P)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), 28029 Madrid, Spain.
Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, National Institute of Health Carlos III, Av. Monforte de Lemos, 5, 28029 Madrid, Spain.

María-José Sánchez (MJ)

Non-Communicable Disease and Cancer Epidemiology Group, Instituto de Investigación Biosanitaria de Granada, ibs.GRANADA, Calle Doctor Azpitarte 4, 18012 Granada, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), 28029 Madrid, Spain.
Andalusian School of Public Health, Cuesta del Observatorio 4, 18080 Granada, Spain.
Department of Preventive Medicine and Public Health, University of Granada, Av. De la Investigación, 11, 18071 Granada, Spain.

Miguel Angel Luque-Fernandez (MA)

Non-Communicable Disease and Cancer Epidemiology Group, Instituto de Investigación Biosanitaria de Granada, ibs.GRANADA, Calle Doctor Azpitarte 4, 18012 Granada, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), 28029 Madrid, Spain.
Andalusian School of Public Health, Cuesta del Observatorio 4, 18080 Granada, Spain.
Department of Noncommunicable Disease Epidemiology, ICON Group, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.

Classifications MeSH